Development of a targeted gene vector platform based on simian adenovirus serotype 24

Journal of Virology

Volumn 84, Issue 19, 2010, Pages 10087-10101

  Belousova, Natalya ^a   Mikheeva, Galina ^a   Xiong, Chiyi ^a   Soghomonian, Suren ^a   Young, Daniel ^a   Le Roux, Lucia ^a   Naff, Katherine ^a   Bidaut, Luc ^a   Wei, Wei ^a   Li, Chun ^a   Gelovani, Juri ^a   Krasnykh, Victor ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NEUTRALIZING ANTIBODY; CYTOKINE; ERBB2 PROTEIN, HUMAN; PRIMER DNA; VIRUS ANTIBODY; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENE VECTOR; HUMAN; HUMAN CELL; IN VITRO STUDY; KUPFFER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; SIMIAN VIRUS; VIRION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CLASSIFICATION; FEMALE; GENE THERAPY; GENETICS; HUMAN ADENOVIRUS; ICE COVER; IMMUNOLOGY; LIVER; LUNG NEOPLASMS; METABOLISM; NUCLEOTIDE SEQUENCE; SECONDARY; SEROTYPING; SPECIES DIFFERENCE; TUMOR CELL LINE; VIROLOGY;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS; MURINAE; SIMIAE; SIMIAN ADENOVIRUS;

ADENOVIRUSES, HUMAN; ADENOVIRUSES, SIMIAN; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BASE SEQUENCE; CELL LINE, TUMOR; CYTOKINES; DNA PRIMERS; DNA, VIRAL; FACTOR X; FEMALE; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; ICE COVER; KUPFFER CELLS; LIVER; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; RECEPTOR, ERBB-2; SEROTYPING; SPECIES SPECIFICITY;

EID: 77956836329     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02425-09     Document Type: Article

References (64)

1. Alauddin, M. M., P. S. Conti, and J. D. Fissekis. 2003. A general synthesis of 2′-deoxy-2′-[18F]fluoro-5-methyl-1-β-D- arabinofuranosyluracil and its 5-substituted nucleosides. J. Label. Comp. Radiopharm. 46:285-289.
2. Alba, R., A. C. Bradshaw, A. L. Parker, D. Bhella, S. N. Waddington, S. A. Nicklin, N. van Rooijen, J. Custers, J. Goudsmit, D. H. Barouch, J. H. McVey, and A. H. Baker. 2009. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114:965-971.
3. Appledorn, D. M., A. Kiang, A. McBride, H. Jiang, S. Seregin, J. M. Scott, R. Stringer, Y. Kousa, M. Hoban, M. M. Frank, and A. Amalfitano. 2008. Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent. Gene Ther. 15:885-901.
4. Arnberg, N., K. Edlund, A. H. Kidd, and G. Wadell. 2000. Adenovirus type 37 uses sialic acid as a cellular receptor. J. Virol. 74:42-48.
5. Belousova, N., N. Korokhov, V. Krendelshchikova, V. Simonenko, G. Mikheeva, P. L. Triozzi, W. A. Aldrich, P. T. Banerjee, S. D. Gillies, D. T. Curiel, and V. Krasnykh. 2003. Genetically targeted adenovirus vector directed to CD40-expressing cells. J. Virol. 77:11367-11377.
6. Belousova, N., V. Krendelchtchikova, D. T. Curiel, and V. Krasnykh. 2002. Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein. J. Virol. 76:8621-8631. (Pubitemid 34864056)
7. Belousova, N., G. Mikheeva, J. Gelovani, and V. Krasnykh. 2008. Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer. J. Virol. 82:630-637.
8. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
9. Bewley, M. C., K. Springer, Y. B. Zhang, P. Freimuth, and J. M. Flanagan. 1999. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 286:1579-1583.
10. Bidaut, L. M., R. Pascual-Marqui, J. Delavelle, A. Naimi, M. Seeck, C. Michel, D. Slosman, O. Ratib, D. Ruefenacht, T. Landis, N. de Tribolet, J. R. Scherrer, and F. Terrier. 1996. Three- to five-dimensional biomedical multisensor imaging for the assessment of neurological (dys) function. J. Digit. Imaging 9:185-198.
11. Chartier, C., E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani, and M. Mehtali. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70:4805-4810.
12. Chirmule, N., K. Propert, S. Magosin, Y. Qian, R. Qian, and J. Wilson. 1999. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 6:1574-1583.
13. Copeland, R. A., D. L. Pompliano, and T. D. Meek. 2006. Drug-target residence time and its implications for lead optimization. Nat. Rev. Drug Discov. 5:730-739.
14. Defer, C., M. T. Belin, M. L. Caillet-Boudin, and P. Boulanger. 1990. Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J. Virol. 64:3661-3673. (Pubitemid 20227188)
15. Dmitriev, I., V. Krasnykh, C. R. Miller, M. Wang, E. Kashentseva, G. Mikheeva, N. Belousova, and D. T. Curiel. 1998. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J. Virol. 72:9706-9713.
16. Farina, S. F., G. P. Gao, Z. Q. Xiang, J. J. Rux, R. M. Burnett, M. R. Alvira, J. Marsh, H. C. Ertl, and J. M. Wilson. 2001. Replication-defective vector based on a chimpanzee adenovirus. J. Virol. 75:11603-11613.
17. Gaggar, A., D. M. Shayakhmetov, and A. Lieber. 2003. CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9:1408-1412.
18. Hasenburg, A., D. C. Fischer, X. W. Tong, A. Rojas-Martinez, R. H. Kaufman, I. Ramzy, P. Kohlberger, M. Orlowska-Volk, E. Aguilar-Cordova, and D. G. Kieback. 2002. Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5. J. Soc. Gynecol. Invest. 9:174-180.
19. Hemminki, A., N. Belousova, K. R. Zinn, B. Liu, M. Wang, T. R. Chaudhuri, B. E. Rogers, D. J. Buchsbaum, G. P. Siegal, M. N. Barnes, J. Gomez- Navarro, D. T. Curiel, and R. D. Alvarez. 2001. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Mol. Ther. 4:223-231.
20. Henry, L. J., D. Xia, M. E. Wilke, J. Deisenhofer, and R. D. Gerard. 1994. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J. Virol. 68:5239-5246.
21. Hong, J. S., and J. A. Engler. 1996. Domains required for assembly of adenovirus type 2 fiber trimers. J. Virol. 70:7071-7078.
22. Kalyuzhniy, O., N. C. Di Paolo, M. Silvestry, S. E. Hofherr, M. A. Barry, P. L. Stewart, and D. M. Shayakhmetov. 2008. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc. Natl. Acad. Sci. U. S. A. 105:5483-5488.
23. Kirby, I., E. Davison, A. J. Beavil, C. P. Soh, T. J. Wickham, P. W. Roelvink, I. Kovesdi, B. J. Sutton, and G. Santis. 2000. Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein. J. Virol. 74:2804-2813.
24. Kirby, I., E. Davison, A. J. Beavil, C. P. Soh, T. J. Wickham, P. W. Roelvink, I. Kovesdi, B. J. Sutton, and G. Santis. 1999. Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR. J. Virol. 73:9508-9514.
25. Korokhov, N., G. Mikheeva, A. Krendelshchikov, N. Belousova, V. Simonenko, V. Krendelshchikova, A. Pereboev, A. Kotov, O. Kotova, P. L. Triozzi, W. A. Aldrich, J. T. Douglas, K. M. Lo, P. T. Banerjee, S. D. Gillies, D. T. Curiel, and V. Krasnykh. 2003. Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge. J. Virol. 77:12931-12940.
26. Krasnykh, V., N. Belousova, N. Korokhov, G. Mikheeva, and D. T. Curiel. 2001. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J. Virol. 75:4176-4183.
27. Krasnykh, V., I. Dmitriev, G. Mikheeva, C. R. Miller, N. Belousova, and D. T. Curiel. 1998. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J. Virol. 72:1844-1852.
28. Lieber, A., C. Y. He, L. Meuse, D. Schowalter, I. Kirillova, B. Winther, and M. A. Kay. 1997. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71:8798-8807.
29. Louis, N., P. Fender, A. Barge, P. Kitts, and J. Chroboczek. 1994. Cell-binding domain of adenovirus serotype 2 fiber. J. Virol. 68:4104-4106. (Pubitemid 24177446)
30. Maes, F., A. Collignon, D. Vandermeulen, G. Marchal, and P. Suetens. 1997. Multimodality image registration by maximization of mutual information. IEEE Trans. Med. Imaging 16:187-198.
31. Magnusson, M. K., P. Henning, S. Myhre, M. Wikman, T. G. Uil, M. Friedman, K. M. Andersson, S. S. Hong, R. C. Hoeben, N. A. Habib, S. Stahl, P. Boulanger, and L. Lindholm. 2007. Adenovirus 5 vector genetically retargeted by an Affibody molecule with specificity for tumor antigen HER2/neu. Cancer Gene Ther. 14:468-479.
32. Magnusson, M. K., S. S. Hong, P. Boulanger, and L. Lindholm. 2001. Genetic retargeting of adenovirus: novel strategy employing " deknobbing" of the fiber. J. Virol. 75:7280-7289.
33. Magnusson, M. K., S. See Hong, P. Henning, P. Boulanger, and L. Lindholm. 2002. Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability. J. Gene Med. 4:356-370.
34. Manickan, E., J. S. Smith, J. Tian, T. L. Eggerman, J. N. Lozier, J. Muller, and A. P. Byrnes. 2006. Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol. Ther. 13:108-117.
35. Mercier, G. T., J. A. Campbell, J. D. Chappell, T. Stehle, T. S. Dermody, and M. A. Barry. 2004. A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1. Proc. Natl. Acad. Sci. U. S. A. 101:6188-6193.
36. Mitraki, A., A. Barge, J. Chroboczek, J. P. Andrieu, J. Gagnon, and R. W. Ruigrok. 1999. Unfolding studies of human adenovirus type 2 fibre trimers. Evidence for a stable domain. Eur. J. Biochem. 264:599-606.
37. Muruve, D. A., M. J. Barnes, I. E. Stillman, and T. A. Libermann. 1999. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10:965-976.
38. Novelli, A., and P. A. Boulanger. 1991. Assembly of adenovirus type 2 fiber synthesized in cell-free translation system. J. Biol. Chem. 266:9299-9303.
39. Orlova, A., M. Magnusson, T. L. Eriksson, M. Nilsson, B. Larsson, I. Hoiden-Guthenberg, C. Widstrom, J. Carlsson, V. Tolmachev, S. Stahl, and F. Y. Nilsson. 2006. Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res. 66:4339-4348.
40. Ory, D. S., B. A. Neugeboren, and R. C. Mulligan. 1996. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. U. S. A. 93:11400-11406.
41. Philipson, L., K. Lonberg-Holm, and U. Pettersson. 1968. Virus-receptor interaction in an adenovirus system. J. Virol. 2:1064-1075.
42. Roberts, D. M., A. Nanda, M. J. Havenga, P. Abbink, D. M. Lynch, B. A. Ewald, J. Liu, A. R. Thorner, P. E. Swanson, D. A. Gorgone, M. A. Lifton, A. A. Lemckert, L. Holterman, B. Chen, A. Dilraj, A. Carville, K. G. Mansfield, J. Goudsmit, and D. H. Barouch. 2006. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 441:239-243.
43. Roelvink, P. W., G. Mi Lee, D. A. Einfeld, I. Kovesdi, and T. J. Wickham. 1999. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing Adenoviridae. Science 286:1568-1571.
44. Roy, S., G. Gao, D. S. Clawson, L. H. Vandenberghe, S. F. Farina, and J. M. Wilson. 2004. Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses. Virology 324:361-372.
45. Roy, S., G. Gao, Y. Lu, X. Zhou, M. Lock, R. Calcedo, and J. M. Wilson. 2004. Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors. Hum. Gene Ther. 15:519-530.
46. Roy, S., G. P. Kobinger, J. Lin, J. Figueredo, R. Calcedo, D. Kobasa, and J. M. Wilson. 2007. Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein. Vaccine 25:6845-6851.
47. Schagen, F. H., F. M. Wensveen, J. E. Carette, T. S. Dermody, W. R. Gerritsen, and V. W. van Beusechem. 2006. Genetic targeting of adenovirus vectors using a reovirus sigma1-based attachment protein. Mol. Ther. 13:997-1005.
48. Sebestyen, Z., J. de Vrij, M. Magnusson, R. Debets, and R. Willemsen. 2007. An oncolytic adenovirus redirected with a tumor-specific T-cell receptor. Cancer Res. 67:11309-11316.
49. Shayakhmetov, D. M., A. Gaggar, S. Ni, Z. Y. Li, and A. Lieber. 2005. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 79:7478-7491.
50. Short, J. J., A. V. Pereboev, Y. Kawakami, C. Vasu, M. J. Holterman, and D. T. Curiel. 2004. Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. Virology 322:349-359.
51. Tomko, R. P., R. Xu, and L. Philipson. 1997. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. U. S. A. 94:3352-3356.
52. Tsuruta, Y., L. Pereboeva, J. N. Glasgow, C. L. Luongo, S. Komarova, Y. Kawakami, and D. T. Curiel. 2005. Reovirus sigma1 fiber incorporated into adenovirus serotype 5 enhances infectivity via a CAR-independent pathway. Biochem. Biophys. Res. Commun. 335:205-214.
53. van Beusechem, V. W., A. L. van Rijswijk, H. H. van Es, H. J. Haisma, H. M. Pinedo, and W. R. Gerritsen. 2000. Recombinant adenovirus vectors with knobless fibers for targeted gene transfer. Gene Ther. 7:1940-1946.
54. van Raaij, M. J., A. Mitraki, G. Lavigne, and S. Cusack. 1999. A triple beta-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein. Nature 401:935-938.
55. Vogels, R., D. Zuijdgeest, R. van Rijnsoever, E. Hartkoorn, I. Damen, M. P. de Bethune, S. Kostense, G. Penders, N. Helmus, W. Koudstaal, M. Cecchini, A. Wetterwald, M. Sprangers, A. Lemckert, O. Ophorst, B. Koel, M. van Meerendonk, P. Quax, L. Panitti, J. Grimbergen, A. Bout, J. Goudsmit, and M. Havenga. 2003. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J. Virol. 77:8263-8271.
56. Waddington, S. N., J. H. McVey, D. Bhella, A. L. Parker, K. Barker, H. Atoda, R. Pink, S. M. Buckley, J. A. Greig, L. Denby, J. Custers, T. Morita, I. M. Francischetti, R. Q. Monteiro, D. H. Barouch, N. van Rooijen, C. Napoli, M. J. Havenga, S. A. Nicklin, and A. H. Baker. 2008. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132:397-409.
57. Wang, H., Y. Liu, Z. Li, S. Tuve, D. Stone, O. Kalyushniy, D. Shayakhmetov, C. L. Verlinde, T. Stehle, J. McVey, A. Baker, K. W. Peng, S. Roffler, and A. Lieber. 2008. In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46. J. Virol. 82:10567-10579.
58. Wickham, T. J., E. J. Filardo, D. A. Cheresh, and G. R. Nemerow. 1994. Integrin αvβ5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127:257-264.
59. 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
60. Wickham, T. J., P. W. Roelvink, D. E. Brough, and I. Kovesdi. 1996. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat. Biotechnol. 14:1570-1573.
61. Wickham, T. J., E. Tzeng, L. L. Shears II, P. W. Roelvink, Y. Li, G. M. Lee, D. E. Brough, A. Lizonova, and I. Kovesdi. 1997. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71:8221-8229.
62. Wikman, M., A. C. Steffen, E. Gunneriusson, V. Tolmachev, G. P. Adams, J. Carlsson, and S. Stahl. 2004. Selection and characterization of HER2/neu-binding affibody ligands. Protein Eng. Des Sel. 17:455-462.
63. Xu, Z., J. Tian, J. S. Smith, and A. P. Byrnes. 2008. Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J. Virol. 82:11705-11713.
64. Zhi, Y., J. Figueredo, G. P. Kobinger, H. Hagan, R. Calcedo, J. R. Miller, G. Gao, and J. M. Wilson. 2006. Efficacy of severe acute respiratory syndrome vaccine based on a nonhuman primate adenovirus in the presence of immunity against human adenovirus. Hum. Gene Ther. 17:500-506.